These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30707681)

  • 1. Acute-phase dynamics and prognostic value of growth differentiation factor-15 in ST-elevation myocardial infarction.
    Rueda F; Lupón J; García-García C; Cediel G; Aranda Nevado MC; Serra Gregori J; Labata C; Oliveras T; Ferrer M; de Diego O; Serra J; Revuelta López E; Bayés-Genís A
    Clin Chem Lab Med; 2019 Jun; 57(7):1093-1101. PubMed ID: 30707681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GDF-15 and TRAIL-R2 are powerful predictors of long-term mortality in patients with acute myocardial infarction.
    Skau E; Henriksen E; Wagner P; Hedberg P; Siegbahn A; Leppert J
    Eur J Prev Cardiol; 2017 Oct; 24(15):1576-1583. PubMed ID: 28762762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth differentiation factor-15 is a predictive biomarker in primary ventricular fibrillation: The RUTI-STEMI-PVF study.
    Garcia-Garcia C; Rueda F; Lupon J; Oliveras T; Labata C; Ferrer M; Cediel G; De Diego O; Rodriguez-Leor O; Carrillo X; Bayes-Genis A
    Eur Heart J Acute Cardiovasc Care; 2020 Nov; 9(4_suppl):S161-S168. PubMed ID: 30175597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth Differentiation Factor-15 Levels at Admission Provide Incremental Prognostic Information on All-Cause Long-term Mortality in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention.
    Bodde MC; Hermans MPJ; van der Laarse A; Mertens B; Romijn FPHTM; Schalij MJ; Cobbaert CM; Jukema JW
    Cardiol Ther; 2019 Jun; 8(1):29-41. PubMed ID: 30701401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of growth-differentiation factor 15 to left ventricular remodeling in ST-segment elevation myocardial infarction.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Avanzas P
    Am J Cardiol; 2011 Oct; 108(7):955-8. PubMed ID: 21784389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy.
    Falkentoft AC; Rørth R; Iversen K; Høfsten DE; Kelbæk H; Holmvang L; Frydland M; Schoos MM; Helqvist S; Axelsson A; Clemmensen P; Jørgensen E; Saunamäki K; Tilsted HH; Pedersen F; Torp-Pedersen C; Kofoed KF; Goetze JP; Engstrøm T; Køber L
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29776961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Gao M; Cheng Y; Zheng Y; Zhang W; Wang L; Qin L
    BMC Cardiovasc Disord; 2017 Jan; 17(1):43. PubMed ID: 28129742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study.
    Farhan S; Freynhofer MK; Brozovic I; Bruno V; Vogel B; Tentzeris I; Baumgartner-Parzer S; Huber K; Kautzky-Willer A
    Cardiovasc Diabetol; 2016 Apr; 15():60. PubMed ID: 27056183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth-differentiation factor 15 for long-term prognostication in patients with non-ST-elevation acute coronary syndrome: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.
    Damman P; Kempf T; Windhausen F; van Straalen JP; Guba-Quint A; Fischer J; Tijssen JG; Wollert KC; de Winter RJ; Hirsch A;
    Int J Cardiol; 2014 Mar; 172(2):356-63. PubMed ID: 24502880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial.
    Fuernau G; Poenisch C; Eitel I; de Waha S; Desch S; Schuler G; Adams V; Werdan K; Zeymer U; Thiele H
    Eur J Heart Fail; 2014 Aug; 16(8):880-7. PubMed ID: 24903195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19.
    Myhre PL; Prebensen C; Strand H; Røysland R; Jonassen CM; Rangberg A; Sørensen V; Søvik S; Røsjø H; Svensson M; Berdal JE; Omland T
    Circulation; 2020 Dec; 142(22):2128-2137. PubMed ID: 33058695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth differentiation factor-15 is associated with cardiovascular outcomes in patients with coronary artery disease.
    Li M; Duan L; Cai YL; Li HY; Hao BC; Chen JQ; Liu HB
    Cardiovasc Diabetol; 2020 Aug; 19(1):120. PubMed ID: 32746821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth-differentiation factor-15 and major cardiac events.
    Lin JF; Wu S; Hsu SY; Yeh KH; Chou HH; Cheng ST; Wu TY; Hsu WT; Yang CC; Ko YL
    Am J Med Sci; 2014 Apr; 347(4):305-11. PubMed ID: 24521768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Incremental Prognostic Value of Cardiovascular Magnetic Resonance After ST-Segment Elevation Myocardial Infarction: A Study of the Collaborative Registry on CMR in STEMI.
    Symons R; Pontone G; Schwitter J; Francone M; Iglesias JF; Barison A; Zalewski J; de Luca L; Degrauwe S; Claus P; Guglielmo M; Nessler J; Carbone I; Ferro G; Durak M; Magistrelli P; Lo Presti A; Aquaro GD; Eeckhout E; Roguelov C; Andreini D; Vogt P; Guaricci AI; Mushtaq S; Lorenzoni V; Muller O; Desmet W; Agati L; Janssens S; Bogaert J; Masci PG
    JACC Cardiovasc Imaging; 2018 Jun; 11(6):813-825. PubMed ID: 28823746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of the Stanniocalcin-2/PAPP-A/IGFBP-4 axis in ST-segment elevation myocardial infarction.
    Cediel G; Rueda F; Oxvig C; Oliveras T; Labata C; de Diego O; Ferrer M; Aranda-Nevado MC; Serra-Gregori J; Núñez J; García C; Bayes-Genis A
    Cardiovasc Diabetol; 2018 Apr; 17(1):63. PubMed ID: 29712555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes.
    Resl M; Clodi M; Vila G; Luger A; Neuhold S; Wurm R; Adlbrecht C; Strunk G; Fritzer-Szekeres M; Prager R; Pacher R; Hülsmann M
    Heart; 2016 Dec; 102(24):1963-1968. PubMed ID: 27456261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
    Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
    Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth differentiation factor-15 levels and the risk of contrast induced nephropathy in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A retrospective observation study.
    Sun L; Zhou X; Jiang J; Zang X; Chen X; Li H; Cao H; Wang Q
    PLoS One; 2018; 13(5):e0197609. PubMed ID: 29791474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease.
    Fluschnik N; Ojeda F; Zeller T; Jørgensen T; Kuulasmaa K; Becher PM; Sinning C; Blankenberg S; Westermann D
    PLoS One; 2018; 13(5):e0197497. PubMed ID: 29771963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.